{"filing":{"accession_number":"0001213900-26-111740","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-16","primary_document":"ea0309254-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026111740/ea0309254-8k_tenon.htm"},"events":[{"id":37332,"run_id":34416,"accession_number":"0001213900-26-111740","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The Company issued a Series B warrant to purchase 125,000 shares of Common Stock as consideration for waiving restrictions on its at-the-market offering. This is a dilutive equity issuance to an institutional investor under Section 4(a)(2) exemption. While the primary transaction is a waiver agreement, the material economic substance is the issuance of equity securities (warrants) that will dilute existing shareholders upon exercise, which is characteristic of dilutive_issuance events.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":[{"id":42009,"accession_number":"0001213900-26-111740","item_number":"1.01","item_title":"Entry into","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company issued a Series B warrant to purchase 125,000 shares of Common Stock as consideration for waiving restrictions on its at-the-market offering. This is a dilutive equity issuance to an institutional investor under Section 4(a)(2) exemption. While the primary transaction is a waiver agreement, the material economic substance is the issuance of equity securities (warrants) that will dilute existing shareholders upon exercise, which is characteristic of dilutive_issuance events.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T21:03:36.498738+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42009,"accession_number":"0001213900-26-111740","item_number":"1.01","item_title":"Entry into","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company issued a Series B warrant to purchase 125,000 shares of Common Stock as consideration for waiving restrictions on its at-the-market offering. This is a dilutive equity issuance to an institutional investor under Section 4(a)(2) exemption. While the primary transaction is a waiver agreement, the material economic substance is the issuance of equity securities (warrants) that will dilute existing shareholders upon exercise, which is characteristic of dilutive_issuance events.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T21:03:36.498738+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-10-22"}]}